2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Lasix is indicated in adults, infants and children for the treatment of oedema associated with congestive heart failure, cirrhosis of the liver and renal disease including the …
Download 2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Advertisement
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
Presentation, Advantan presentation uses, Advantan, Uses, Methylprednisolone aceponate, Methylprednisolone, Aceponate
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Draft, Good, Practices, Manufacturing, Edition, Edition draft, Good manufacturing practice
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
ACTIQ Patients must require and use around -the …
www.actiq.comHIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ACTIQ safely and effectively. See full prescribing information for ACTIQ.
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
www.ema.europa.euFasturtec is a recombinan t urate-oxidase enzyme produced by genetically modified Saccharomyces cerevisiae strain. Rasburicase is a tetrameric protein with identical subunits of a molecular mass of
PRODUCT INFORMATION Anpec - Medicines
www.medicines.org.auAnpec – Product Information 2 Angina Pectoris Verapamil dilates the main coronary arteries and coronary arterioles, both in normal and ischaemic regions, and is a potent inhibitor of coronary artery spasm, whether spontaneous or ergonovine-induced.
Aratac - Medicines
www.medicines.org.auAratac – Product Information 2 The site and mode of action of amiodarone can be summarised in terms of its effect on myocardial electrophysiology: Myocardial Electrophysiology
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzCCDS171217 Page 1 of 32 RISPERDAL CONSTA (180327)ADS RISPERDAL CONSTA® risperidone NEW ZEALAND DATA SHEET 1. PRODUCT NAME RISPERDAL CONSTA® 25 mg/2 ml Suspension for injection RISPERDAL CONSTA® 37.5 mg/2 ml Suspension for injection RISPERDAL CONSTA® 50 mg/2 ml Suspension for injection 2.
RxFiles Q&A Summary
www.rxfiles.caRxFiles: Q&A Summary www.RxFiles.ca ‐ Oct 2013 Debbie Bunka Chronic Insomnia in Older Adults Sleep patterns naturally change as one gets older. Compared to younger people, older adults: 1,2,3 • Sleep fewer hours & take longer to fall asleep
Protocol for the Use and Administration of Clozapine
www.wales.nhs.ukStatus: Guideline Issue date: 30/01/2014 Revised: July 2015 Approved by: ABUHB Mental Health D+T Review by date: 30/01/2017 4. Inpatient Initiation of clozapine Prescribing, dispensing and administering clozapine should be done following the Inpatient
DOSAGE FORMS AND STRENGTHS------------------- …
docs.boehringer-ingelheim.comPage 2 of 28 FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE 1.1 Parkinson's Disease MIRAPEX tablets are indicated for the treatment of …